The following is a summary of the Materialise NV (MTLS) Q1 2024 Earnings Call Transcript:

Financial Performance:

• Materialise NV's total Q1 2024 revenue slightly decreased by 3.4% to €63.6 million due to weak prototyping demand and the shift to cloud and subscription-based business model in the Software segment.

• Gross margin, however, increased to 56.5% from 55.9% in the same period the previous year.

• Adjusted EBIT amounted to €2.7 million, representing 4.2% of revenue while net profit was stable at €3.6 million or €0.06 per share.

• The company's net cash position at the end of Q1 2024 was €69.2 million, an increase of €6 million from the start of the quarter.

Business Progress:

• Materialise NV made significant progress on its strategic priorities, launching new technologies, and extending its reach into new markets and segments.

• Growth was seen in the market adoption of personalized medical cases and developments were made in new software solutions.

• The move from prototyping to larger certified manufacturing projects is underway and they entered the trauma market with short lead times in the U.S. - expected to be a key growth driver.

• They are focusing on untapped markets and investing in developing offerings for end-use product manufacturing, especially in software units. In addition, their investment in the CO-AM platform, which helps customers scale in the production of end-use products, continues to grow.

More details: Materialise IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.